Boldenone Undecylenate
Equipoise · EQ
Half-life
14 days
Time to Peak
4 days
Steady State
~70 days
Bioavailability
100%
Dose Range
200–800 mg
Frequency
Weekly
Overview
Very long-acting boldenone ester. Originally a veterinary product for horses (Equipoise). No FDA-approved human formulation exists. One of the most commonly used non-medical AAS. The undecylenate ester (11-carbon, unsaturated) provides very slow, sustained release. Known for increasing red blood cell production (erythropoiesis) and appetite stimulation. Very long detection time (5+ months) due to long-lived metabolites. Harm reduction: Monitor hematocrit closely — boldenone strongly stimulates erythropoiesis. Elevated RBC/hematocrit increases blood viscosity and cardiovascular risk. Consider regular blood donation or therapeutic phlebotomy if hematocrit exceeds 54%.
Mechanism of Action
1-dehydrotestosterone derivative. Binds androgen receptor. Aromatizes to estradiol at roughly 50% the rate of testosterone. Strong erythropoietic effect via EPO stimulation.
Dosing Information
| Route | Dose Range | Half-life | Tmax | Frequency |
|---|---|---|---|---|
| Intramuscular (IM) | 200–800 mg | 14 days | 4 days | Weekly, Every 2 weeks |
Storage & Handling
Room temperature — Store at 20-25C. Protect from light. Oil-based solution.
Used in Regimens
1 regimenData Sources
- animal data Equine pharmacokinetic studies (various)
- Community SteroidPlotter half-life: 336 hours (14 days)
Related Tools
Track Boldenone Undecylenate with Doseline
Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.